Skip to main content
Equibles
IKT logo

IKT · Inhibikase Therapeutics, Inc. · Analyst Estimates

Track IKT — free

Use IKT with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research IKT.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$2.34 +0.01 (+0.43%) At close · Sep 11
Russell 2000 member Rebalance outlook locked
Market Cap
$326.51M
Shares
139.54M

Analyst Estimates

Compare analyst forecasts for Inhibikase Therapeutics, Inc. across metrics and forecast periods.

Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.

Only independently verified consensus published through the company's investor-relations sources is available.

Consensus not yet available

Only independently verified consensus published through the company's investor-relations sources is available.

Key facts CIK 1750149 CUSIP 45719W205 13F (30d) 60 filings 60 filers Visit website Investor relations